Значения термина resistant gram на английском

Background: Infections caused by carbapenem- resistant gram-negative bacilli are an emerging public health threat.

Infections due to resistant gram-negative bacilli continue to cause unacceptable morbidity and mortality rates.

Glycopeptide antibiotics have long served as drugs of last resort for the treatment of antibiotic- resistant gram-positive bacterial infections.

Ceftazidime-avibactam is a newly approved agent combining ceftazidime and a novel β-lactamase inhibitor with activity against multidrug- resistant gram-negative bacteria.

Dalbavancin will likely have a significant role in outpatient intravenous therapy for patients with potentially serious drug- resistant gram-positive coccal infections.

As part of the study, we also attempted to find the prevalence of blaNDM-like gene among carbapenem- resistant gram negative infections.

Objectives: To explore contemporary antibiotic management of infections caused by carbapenem- resistant Gram-negative bacteria in hospitals.

For resistant Gram-negatives, there are almost no drugs left, and none on the immediate horizon.

The results suggest that GWLK-Lucilin-CPD-His8 represents a potential candidate for therapy against multidrug resistant Gram-negative bacteria.

We hypothesized that SBTs could play a renewed role in monitoring antibiotic treatment of multidrug- resistant Gram-negative infections.

Methods: A prospective study was designed including critically ill patients treated with tigecycline for multidrug- resistant Gram-negative infections.

The emergence of multi-drug- resistant Gram-negative bacteria, including carbapenem-resistant Enterobacteriaceae, is a major health problem that necessitates the development of new antibiotics.

The selection of daptomycin- resistant Gram-positive skin flora with the potential of causing invasive disease may be a concern during prolonged courses of daptomycin.

The aim of this study is to explore the impact of prior community antibiotic usage on hospital-detected multidrug- resistant Gram-negative (MRGN) incidence rate.